CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-05 | CHILDS JOHN W Director | Grant or award · Stock Options (Right to buy) | +31,716 | 31,716 | ||
| 2025-05-05 | HUGIN ROBERT J Director | Grant or award · Stock Options (Right to buy) | +31,716 | 31,716 | ||
| 2025-03-04 | CHILDS JOHN W Director | Purchase | +28,400 | $30.43 | $864K | 2,323,971 |
| 2025-03-04 | CHILDS JOHN W Director | Purchase | +25,000 | $30.39 | $760K | 2,320,571 |
| 2025-03-04 | CHILDS JOHN W Director | Purchase | +3,400 | $30.73 | $104K | 24,452 |
| 2025-03-04 | CHILDS JOHN W Director | Purchase | +3,400 | $30.73 | $104K | 76,570 |
| 2025-03-04 | CHILDS JOHN W Director | Purchase | +900 | $30.73 | $28K | 25,291 |
| 2025-01-05 | Car Bruce Chief Scientific Officer | Option exercise | +4,750 | 7,133 | ||
| 2025-01-05 | Car Bruce Chief Scientific Officer | Shares withheld for taxes | −2,331 | $38.64 | $90K | 4,802 |
| 2025-01-05 | Car Bruce Chief Scientific Officer | Grant or award · Stock Options (Right to buy) | +112,000 | 112,000 | ||
| 2025-01-05 | Car Bruce Chief Scientific Officer | Grant or award · Restricted Share Unit Award | +19,000 | 19,000 | ||
| 2025-01-05 | Car Bruce Chief Scientific Officer | Option exercise · Restricted Share Unit Award | −4,750 | 14,250 | ||
| 2025-01-05 | Gentile Kimberly SVP, Clinical Operations | Option exercise | +3,750 | 99,719 | ||
| 2025-01-05 | Gentile Kimberly SVP, Clinical Operations | Shares withheld for taxes | −1,956 | $38.64 | $76K | 97,763 |
| 2025-01-05 | Gentile Kimberly SVP, Clinical Operations | Grant or award · Stock Options (Right to buy) | +91,000 | 91,000 | ||
| 2025-01-05 | Gentile Kimberly SVP, Clinical Operations | Grant or award · Restricted Share Unit Award | +15,000 | 15,000 | ||
| 2025-01-05 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Restricted Share Unit Award | −3,750 | 11,250 | ||
| 2025-01-05 | Clark George C. VP, Chief Accounting Officer | Option exercise | +2,500 | 66,168 | ||
| 2025-01-05 | Clark George C. VP, Chief Accounting Officer | Shares withheld for taxes | −1,117 | $38.64 | $43K | 65,051 |
| 2025-01-05 | Clark George C. VP, Chief Accounting Officer | Grant or award · Stock Options (Right to buy) | +30,000 | 30,000 |
Page 3 of 18 · 355 trades